Delivery Order SPE2D021DA002-SPE2D325F007T
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,146.40 for Adacel TDAP vaccine vials (0.5 mL) on August 4, 2025. The award carries an ultimate completion date of August 7, 2025 and was issued without a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,518.30 on August 11, 2025, for the supply of Adacel TDAP vaccine vials (0.5ml). This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, carries no set-aside designation and is being funded by the Defense Department's Medical Supply Chain. The award represents a specific issuance under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,821.96 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025. The contract calls for delivery of Adacel TDAP vaccine in 0.5mL vials to support Department of Defense healthcare facilities. This delivery order was issued without set-aside designation and carries an ultimate completion date of August 21,...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a firm fixed-price delivery order valued at $6,073.20 to DMS Pharmaceutical Group Inc. for the supply of Adacel TDAP vaccine vials (0.5ML). The award, issued on September 10, 2025, with an ultimate completion date of September 15, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the SPE2DB program to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,219.04 delivery order is for the supply of ADACEL TDAP VIAL, with a completion date of June 20, 2024. The order is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of ADACEL TDAP VIAL 0.5ML. The contract has a firm fixed price of $1,821.96 and a completion date of June 13, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois, that specializes in providing a comprehensive range of pharmaceutical products to federal agencies, including the Department of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 4, 2025, by the Defense Logistics Agency for the supply of Boostrix TDAP vaccine syringes (0.5ML) with a ceiling value of $18,152.32. This firm fixed-price delivery order, which must be completed by September 5, 2025, represents a routine pharmaceutical supply transaction under DMS Pharmaceutical Group's existing Indefinite Delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of 4,568,380,483 units of ADACEL TDAP VIAL 0.5ML, a pharmaceutical product, with a ceiling value of $1,518.30 and a completion date of May 30, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of prescription...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $1,906.16 firm fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain for tetanus/diphtheria vaccines. Awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, this delivery order was issued without a set-aside designation. The contract represents a continuation of DMS Pharmaceutical Group's role as a critical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 27, 2025, by the Defense Logistics Agency for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. The contract carries a ceiling value of $17,048.40 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 28, 2025. No set-aside designation was utilized for this award, and the place of...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F007TDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order contract on April 21, 2025, for ADACEL TDAP VIAL with a ceiling value of $1,214.64. This firm fixed-price delivery order was issued by the Defense Logistics Agency under its Medical Supply Chain program without a set-aside designation. The award represents a continuation of the company's substantial involvement in federal pharmaceutical supply, leveraging its position as a critical supplier within the Department of Defense healthcare system. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The parent IDC enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, vaccines, and medical consumables to support military health facilities worldwide. The ADACEL TDAP VIAL delivery order specifically addresses vaccine supply requirements within this broader pharmaceutical distribution framework, with an ultimate completion date of April 22, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 4/21/25 |